Table 3.

Description of the whole sample in T3 according to the type of treatment. (N: 47). Statistically significant differences (p-value ≤ 0.05) are underlined in bold.

	T3
	RFT		RED		p-Value
	Mean ± SD	Median (Min to Max)	Mean ± SD	Median (Min to Max)
Proportions (%)	27 (57.40)		20 (42.60)
Age (years)	40.26 ± 12.33	38 (19 to 69)	45.4 ± 16.71	47.5 (17 to 70)
Gender
Male	15 (55.60)		8 (40.00)
Female	12 (44.40)		12 (60.00)		0.29
Disease
CD	13 (48.10)		9 (45.00)		0.83
UC	14 (51.90)		11 (55.00)
GM-CSF (pg/mL)	1.78 ± 6.4	0 (0 to 32.05)	0 ± 0	0 (0 to 0)	0.02
IFN-α (pg/mL)	7.02 ± 4.69	9.45 (0 to 11.45)	7.59 ± 4.67	9.25 (0 to 14.65)	0.99
IFN-γ (pg/mL)	61.09 ± 140.83	0 (0 to 662.92)	15.71 ± 41.3	0 (0 to 153.83)	0.09
TNFα (Detectable)	6 (22.20)		--		0.03
CRP (mg/dL)	0.87 ± 1.07	0.31 (0.05 to 3.8)	0.56 ± 1.33	0.05 (0.05 to 5.29)	0.03
IL-10 (pg/mL)	55.45 ± 85.88	32.06 (0 to 431.89)	22.02 ± 27.41	0 (0 to 75.96)	0.12
IL-12 (pg/mL)	73.19 ± 231.55	0 (0 to 1134.84)	6.87 ± 23.05	0 (0 to 98.36)	0.32
IL-17A (pg/mL)	4.36 ± 6.91	2.76 (0 to 34.69)	1.88 ± 2.68	0 (0 to 10.4)	0.11
IL-2 (pg/mL)	0.92 ± 4.76	0 (0 to 24.72)	0 ± 0	0 (0 to 0)	0.41
IL-4 (pg/mL)	25.34 ± 45.52	10.55 (0 to 228.54)	7.4 ± 13.59	0 (0 to 49.54)	0.06
IL-5 (pg/mL)	11.1 ± 31.14	0 (0 to 147.07)	0.82 ± 3.68	0 (0 to 16.44)	0.09
IL-6 (pg/mL)	1.79 ± 9.31	0 (0 to 48.38)	0 ± 0	0 (0 to 0)	0.41
IL-9 (pg/mL)	23.13 ± 61.23	0 (0 to 290.69)	4.98 ± 15.46	0 (0 to 56.2)	0.19
IL-1β (pg/mL)	34.13 ± 146.54	1.93 (0 to 765.91)	6.34 ± 8.5	3.36 (0 to 25.93)	0.88
Folate (ng/mL)	7.07 ± 6.53	4.5 (1.7 to 28)	9.58 ± 6.65	7.05 (2.6 to 25)	0.06
Vitamin B12 (pg/mL)	260.44 ± 121.62	235 (83 to 533)	226.45 ± 102.92	207 (96 to 566)	0.32
Vitamin D (ng/mL)	20.07 ± 8.62	21.8 (4.6 to 39.3)	20.4 ± 7.38	19.45 (13.2 to 46.4)	0.69